Gene · 9507
Papers2,479
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,479
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single‑cell sequencing, genetics, and epigenetics reveal mesenchymal stem cell senescence in osteoarthritis (Review). | Int J Mol Med | 2024 | 37937669 | PubTator, text mining | PubMed |
| Identification of CD64 as a marker for the destructive potential of synovitis in osteoarthritis. | Rheumatology (Oxford) | 2024 | 37341635 | PubTator, text mining | PubMed |
| Tumor microenvironment-based signatures distinguish intratumoral heterogeneity, prognosis, and immunogenomic features of clear cell renal cell carcinoma. | J Natl Cancer Cent | 2023 | 39035192 | PubTator, text mining | PubMed |
| Load-induced blood marker kinetics in patients with medial knee compartment osteoarthritis are associated with accumulated load and patient reported outcome measures. | F1000Res | 2023 | 38882712 | PubTator, text mining | PubMed |
| A Novel COCH p.D544Vfs*3 Variant Associated with DFNA9 Sensorineural Hearing Loss Causes Pathological Multimeric Cochlin Formation. | Life (Basel) | 2023 | 38255649 | PubTator, text mining | PubMed |
| Visceral adipose tissue and osteoarthritis, a two-sample Mendelian randomized study. | Front Med (Lausanne) | 2023 | 38249972 | PubTator, text mining | PubMed |
| Chemokines in Cartilage Regeneration and Degradation: New Insights. | Int J Mol Sci | 2023 | 38203552 | PubTator, text mining | PubMed |
| Cellular and Molecular Mechanisms Activated by a Left Ventricular Assist Device. | Int J Mol Sci | 2023 | 38203459 | PubTator, text mining | PubMed |
| Current status and development direction of immunomodulatory therapy for intervertebral disk degeneration. | Front Med (Lausanne) | 2023 | 38179277 | PubTator, text mining | PubMed |
| Skipping of FCER1G Exon 2 Is Common in Human Brain But Not Associated with the Alzheimer's Disease Genetic Risk Factor rs2070902. | J Alzheimers Dis Rep | 2023 | 38143775 | PubTator, text mining | PubMed |
| Investigation of Glycosaminoglycans in Urine and Their Alteration in Patients with Juvenile Idiopathic Arthritis. | Biomolecules | 2023 | 38136608 | PubTator, text mining | PubMed |
| Exploratory study on the mechanism of necrotic effect of nourishing cells in the context of genital tract infection in premature rupture of membranes. | Medicine (Baltimore) | 2023 | 38115314 | PubTator, text mining | PubMed |
| Exerkines and osteoarthritis. | Front Physiol | 2023 | 38107476 | PubTator, text mining | PubMed |
| Chondroprotective effects of Protaetia brevitarsis seulensis larvae as an edible insect on osteoarthritis in mice. | Food Sci Nutr | 2023 | 38107146 | PubTator, text mining | PubMed |
| LimoRhyde2: Genomic analysis of biological rhythms based on effect sizes. | PLoS One | 2023 | 38096249 | PubTator, text mining | PubMed |
| Osteoporosis and osteoarthritis: a bi-directional Mendelian randomization study. | Arthritis Res Ther | 2023 | 38093316 | PubTator, text mining | PubMed |
| pH-sensing G protein-coupled orphan receptor GPR68 is expressed in human cartilage and correlates with degradation of extracellular matrix during OA progression. | PeerJ | 2023 | 38077417 | PubTator, text mining | PubMed |
| Regulation of Peptidase Activity beyond the Active Site in Human Health and Disease. | Int J Mol Sci | 2023 | 38069440 | PubTator, text mining | PubMed |
| Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal muscles. | Acta Neuropathol Commun | 2023 | 38066589 | PubTator, text mining | PubMed |
| A novel biomarker of MMP-cleaved cartilage intermediate layer protein-1 is elevated in patients with rheumatoid arthritis, ankylosing spondylitis and osteoarthritis. | Sci Rep | 2023 | 38066013 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9507/papers?page=6